|
V.LBL.H
|
Given 36.6% gross profit margin, it is not a bad quarter. EBITDA is also one...
|
|
V.LBL.H
|
The market doesn't like surprise. Guy Cook overpromised it's positive...
|
|
V.LBL.H
|
LBL tried to compare 2016Q4 vs. 2015Q4 in order to build a few shining...
|
|
PMN
|
Thanks nrgzr for the useful information. However, I don't think...
|
|
V.LBL.H
|
Guy Cook, "We expect to be cash flow positive and profitable here in the...
|
|
V.AQS
|
Agree. However, should AQS be able to survive for another year,it is indeed a...
|
|
V.LBL.H
|
Generally speaking, a discount more than 10% for PP is not uncommon. Among...
|
|
V.LBL.H
|
"The proceeds from the Offering will be used for general working capital...
|
|
V.AQS
|
Its business model is fine. The only challenge is its ability of financing...
|
|
V.LBL.H
|
Thanks Laroplex. I would be more optimistic about LBL s/p in long term. A...
|
|
V.LBL.H
|
Be patient MaterialWorld. LBL is going to be cash positive and profitable...
|
|
COTQF
|
Agreed. Based on statistics, 5 out of 5000 candidates in preclinical got a...
|
|
COTQF
|
Unfortunately, I couldn't find it anywhere either. It is a very short...
|
|
COTQF
|
I was in the conference call. Alison explained that there were insufficient...
|
|
COTQF
|
http://www.bloodjournal.org/content/128/22/2757
|
|
COTQF
|
Possible revenue - Rosalind. COTI-2 trial third cohort delayed in completion...
|
|
COTQF
|
Don't know what is going to happen. Usually a new CEO would naturally...
|
|
COTQF
|
I guess two points of the story. 1. Wayne is good at R&D; 2. Wayne is NOT...
|
|
V.AQS
|
Agreed. The risk of not being approved is little. However, on the other side,...
|
|
V.AQS
|
Unfortunately, this is not going to be a quick "win" stock. If it...
|